Sort
30,917 grants matching “tumor microenvironment”
Understanding the Impact of Microscale and Nanoscale Heterogeneity and Resistance
$461,333Joe W. Gray · Oregon Health & Science University · U54 · FY2020 · CA
Targeting UHRF1 in combinational immunotherapy
$461,315Xiao-Fan Wang · Duke University · R01 · FY2022 · CA
Optimal control models of epithelial-mesenchymal transition for the design of pancreas cancer combination therapy
$461,276Matthew J Lazzara · University Of Virginia · U01 · FY2020 · CA
Informatics for Integrative Brain Tumor Whole Slide Analysis
$461,236Joel H Saltz · Emory University · R01 · FY2012 · LM
Mechanical Stress and Lung Tumor Progression
$461,181Jeffrey A. Weiss · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
Mechanisms of cytokine driven tumor elicited inflammation in colorectal cancer
$461,149Sergei I Grivennikov · Cedars-Sinai Medical Center · R01 · FY2020 · CA
Mechanisms of cytokine driven tumor elicited inflammation in colorectal cancer
$461,092Sergei I Grivennikov · Cedars-Sinai Medical Center · R01 · FY2021 · CA
Targeting UHRF1 in combinational immunotherapy
$461,025Xiao-Fan Wang · Duke University · R01 · FY2023 · CA
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors
$460,981Scott Rothbart · Coriell Institute For Medical Research · P50 · FY2024 · CA
Cell-Selective CpG-STAT3 Inhibitors for Radioimmunotherapy of Malignant Glioma
$460,943Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Intracellular Trafficking and Signaling Of The B-cell Antigen Receptor
$460,941Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Tumor Immune MicroEnvironment Facility
$460,935Wiem Lassoued · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Molecular mechanisms and therapeutic principles of VISTA+ triple-negative breast cancers
$460,899Joshua James Gruber · Ut Southwestern Medical Center · R01 · FY2025 · CA
Proj. 2: Combining immune checkpoint blockade with T cell activation
$460,878E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2024 · CA
Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas
$460,837Duane A. Mitchell · University Of Florida · R01 · FY2015 · CA
The role of GPR133 in glioblastoma
$460,820Dimitris G. Placantonakis · New York University School Of Medicine · R01 · FY2019 · NS
The role of GPR133 in glioblastoma
$460,820Dimitris G. Placantonakis · New York University School Of Medicine · R01 · FY2020 · NS
Mechanisms of Tumor Cell Dormancy and Tumor Recurrence
$460,765Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Translation of a novel combination therapy approach for non-Hodgkin lymphoma
$460,749Shruthi Naik · Mayo Clinic Rochester · U01 · FY2025 · CA
Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain
$460,702Cyrus M Ghajar · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Lymph node-targeted codelivery of albumin-binding peptide antigens and di-adjuvant for melanoma combination immunotherapy
$460,692Guizhi Zhu · Virginia Commonwealth University · R01 · FY2022 · CA
Therapeutic Targeting of Macrophage PI3Kgamma in HNSCC
$460,674Judith A. Varner · University Of California, San Diego · R01 · FY2019 · CA
An image-guided immunotherapy and hyperthermia delivery device to overcome barriers to tumor immunity for advanced hepatocellular carcinoma
$460,631Rahul Anil Sheth · University Of Tx Md Anderson Can Ctr · R37 · FY2023 · CA
Regulation of lung cancer growth and metastasis by an actionable driver of vesicle biogenesis in the Golgi
$460,592Jonathan M Kurie · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Dissecting FAK-regulated oncogenic signaling programs in ovarian cancer
$460,555David D Schlaepfer · University Of California, San Diego · R01 · FY2023 · CA